Cover Image

Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts

Abstract Background Long-term use of anti-resorptive or anti-angiogenic drugs in cancer patients with odontogenic infections may lead to medication-related osteonecrosis of the jaw (MRONJ). This study investigated whether anti-angiogenic agents aggravate MRONJ occurrence in anti-resorptive-treated p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ning Zhao (Author), Qing-xiang Li (Author), Yi-fei Wang (Author), Qiao Qiao (Author), Hong-yuan Huang (Author), Chuan-bin Guo (Author), Yu-xing Guo (Author)
Format:	Book
Published:	BMC, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
by: Petcu Eugen B, et al.
Published: (2012)

Oral administration of Bifidobacterium breve improves anti-angiogenic drugs-derived oral mucosal wound healing impairment via upregulation of interleukin-10
by: Qingxiang Li, et al.
Published: (2023)

Drug-induced osteonecrosis of the jaw: the state of the art
by: A. Fassio, et al.
Published: (2017)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)
by: Yumiko Ohbayashi, et al.
Published: (2019)

Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discovery
by: Chimote G, et al.
Published: (2014)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication)
by: Makoto Tsuchimochi, et al.
Published: (2019)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)
by: Akira Baba, et al.
Published: (2019)

Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw
by: Yoshimasa Kitagawa, et al.
Published: (2019)

Osteonecrosis of the Jaw
by: Božana Lončar Brzak, et al.
Published: (2023)

Tetrahedral framework nucleic acid carrying angiogenic peptide prevents bisphosphonate-related osteonecrosis of the jaw by promoting angiogenesis
by: Dan Zhao, et al.
Published: (2022)

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan
by: Takahiko Shibahara
Published: (2019)

New groups of drugs suspected in the medication-related osteonecrosis of the jaws (MRONJ)
by: Mel Mupparapu, et al.
Published: (2017)

Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease
by: Yusaku Matsuda, et al.
Published: (2019)

Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012)

Letter to the editor regarding "Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw"
by: E. Nastro Siniscalchi, et al.
Published: (2020)

The biological mechanisms of the antiresorptive therapy of osteoporosis, and the antiresorptive drug related osteonecrosis of jaws
by: István Gera, et al.
Published: (2024)

Osteonecrosis of the Jaws in Treatment with Bisphosphonates
by: M. Machálka, et al.
Published: (2006)

Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018)

Bisphosphonate-associated osteonecrosis of the jaws
by: Rajiv S Desai, et al.
Published: (2012)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012)

Effect of anti-angiogenic drugs along with chemotherapy in breast cancer treatment: review article
by: Najibeh Nasiri, et al.
Published: (2019)

Effect of gingival fibroblasts and ultrasound on dogs' root resorption during orthodontic treatment
by: Jacqueline Crossman, et al.
Published: (2017)

Dentists' Awareness of Medication-Related Osteonecrosis of the Jaw (Risk Factors, Drugs, and Prevention) in the Republic of Croatia
by: Sven Bival, et al.
Published: (2023)

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database
by: Inada A, et al.
Published: (2018)

Is the combination of pentoxifylline and tocopherol really effective in the treatment of drug-induced osteonecrosis of the jaws? Literature review
by: Samir Mainassara Chekaraou, et al.
Published: (2022)

Bisphosphonate-related osteonecrosis of the jaw: An insight
by: Shalini Kapoor, et al.
Published: (2013)

ZOLEDRONATE-ASSOCIATED RECURRENCE OF OSTEONECROSIS OF JAWS
by: Rosen Tsolov, et al.
Published: (2020)

Review of the effect of biphosphonates on jaw osteonecrosis
by: Afshin Tahmasebi, et al.
Published: (2011)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014)

The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems
by: Lu Lu, et al.
Published: (2019)

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more
by: Zhi-Bin Wang, et al.
Published: (2023)

Computational Drug Repositioning for Peripheral Arterial Disease: Prediction of anti-inflammatory and pro-angiogenic therapeutics
by: Liang-Hui eChu, et al.
Published: (2015)

Auranofin, an Anti-rheumatic Gold Drug, Aggravates the Radiation-Induced Acute Intestinal Injury in Mice
by: Eun Sang Lee, et al.
Published: (2019)

The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia
by: Pooneh Nikuei, et al.
Published: (2015)

Multiple-Drugs-Related Osteonecrosis of the Jaw in a Patient Affected by Multiple Myeloma: A Case Report
by: Mario Caggiano, et al.
Published: (2023)

Schemes for Drug-Induced Treatment of Osteonecrosis of Jaws with Particular Emphasis on the Influence of Vitamin D on Therapeutic Effects
by: Filip Michalak, et al.
Published: (2021)

Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
by: Andrea Cassoni, et al.
Published: (2016)

BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW AND DENTAL IMPLANTS
by: Ala Hassan A. Qamheya, et al.
Published: (2016)

Medication-related osteonecrosis of the jaw: Prosthodontic considerations
by: Islam E. Ali, et al.
Published: (2022)

BISPHOSPHONATE INDUCED OSTEONECROSIS OF THE JAWS AND CURRENT THERAPIES
by: Damla Torul, et al.
Published: (2017)